ArticlePloS one2025
Green synthesized silver nanoparticles from Moringa: Potential for preventative treatment of SARS-CoV-2 contaminated water.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biogenic silver nanoparticles have been reported as good antimicrobial candidates. In this study, we synthesized and characterized silver nanoparticles using aqueous leaf extracts of Moringa oleifera (AgNPmo) and investigated their antimicrobial and antiviral activities. The AgNPmo demonstrated antibacterial activity against Pseudomonas aeruginosa and Staphylococcus aureus, with concentration-dependent zones of inhibition ranging from 6.5-15.5 mm and 0-7 mm, respectively. Cytotoxicity was assessed on Vero cells using a CCK-8 assay, which revealed an IC50 value of 38 µg/ml, indicating relatively low toxicity at effective concentrations. The antiviral activity against SARS-CoV-2 was confirmed using quantitative RT-PCR: AgNPmo exposure led to a time- and dose-dependent increase in Ct values for ORF1ab and N genes, with the strongest inhibition observed after 48 h. These results provide direct evidence of both antimicrobial and antiviral activity. The green synthesis using Moringa extracts offers added advantages by employing phenolic and flavonoid compounds as natural reducing and capping agents, making the process eco-friendly and biocompatible. While direct wastewater treatment was not tested, these findings highlight the advantages of Moringa leaf extract as a natural reducing and capping agent that enabled rapid, eco-friendly AgNP formation, while the resulting AgNPmo demonstrated antimicrobial and antiviral activity. Thus, AgNPmo represents a promising, sustainable option for point-of-use disinfection and potential environmental water treatment.".
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.